FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the directed share issue without payment to the Company itself

by NASDAQ Market News April 16, 2018

NASDAQ Market News
Click here to email author

Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM and in Number of Unplanned Visits/Hospital Admissions Due to OM

Ads